The biggest news of 2016 for the German industrial conglomerate’s healthcare business came mid-year, with a global rebranding as Siemens Healthineers. Before and after that were a string of clearances and approvals from the FDA. (Notably, the U.S. safety watchdog gave the nod to the Sysmex CS-5100 and Xprecia Stride hemostasis analyzers; the Biograph Horizon PET/CT scanner; a trio of new mobile C-arms; stand-alone 3D breast screening for the Mammomat Inspiration; and the dual-source CT scanner Somatom Drive.)

Siemens Healthineers also inked several deals with a range of partners: a molecular testing pact with lab equipment giant Thermo-Fisher, a global alliance with IBM Watson Health for population health management and an outcomes studies agreement with Northwell Health, to name a few.

On the M&A trail, late in 2016 the company acquired open connectivity provider Conworx Technology and, as of the time of this writing, had added workflow management provider Medicalis and announced the intent to acquire the Epocal blood diagnosis business from Alere.

* Revenues from Siemens Healthineers segment.